UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Details
Sales, net (notes 1, 3, 9 and 11)	$ 49,054	$ 42,178	$ 46,904
Cost of goods sold	18,137	16,630	17,438
Gross profit	30,917	25,548	29,466
Sales and marketing	1,414	1,554	1,738
Research and development	526	486	483
General and administrative	10,097	9,800	9,613
Operating income	18,880	13,708	17,632
Dividend and interest income	166	112	254
Royalty income (note 12)	15	20	6
Other, net	0	0	(8)
Income before provision for income taxes	19,061	13,840	17,884
Provision for income taxes (note 7)	4,273	3,042	3,157
Net income	$ 14,788	$ 10,798	$ 14,727
Earnings per common share (basic) (note 1)	$ 4.05	$ 2.95	$ 3.96
Earnings per common share (diluted) (note 1)	$ 4.04	$ 2.94	$ 3.94
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ (773)	$ 1,502	$ 1,507
Total comprehensive income	$ 14,015	$ 12,300	$ 16,234